SBEAD is a cross species (rabbit, mouse, alpaca and more) platform for monoclonal antibody development. When used in rabbits, our special rabbit strains or transgenic lines can be used to further enhance the antibody capability. The advantages of the platform include:

miCas9 is a fusion protein of the wild type Streptococcus pyogenes Cas9 (spCas9) with a 36 amino acid long fragment coded by BRCA2 exon 27 (Brex27). In comparison to spCas9

ATGC founders are the pioneers in adopting the cutting-edge genome editing techniques for developing transgenic rabbits. Our expert team has over a decade’s experience in targeting strategy design

ATGC’s BioUltra technique is an in vivo antibody labeling technique. It achieves the labeling of antibodies with various ultrasensitive fluorescent or luminescent tags during the biological production

Epitope mapping is critical for identifying antibody’s applications in therapeutics and diagnosis. ATGC’s BioUltra labeled antibodies can be used directly in epitope binning analysis, without the need of expensive instruments